...also received five-year warrants to purchase 7.5 million shares at $1.25 per share. Investors included Xmark Opportunity Funds...

...Gordon, a general partner at OrbiMed Advisors LLC; and Mitchell Kaye, chief investment officer at Xmark Opportunity Funds...